Malady Kyle โ EVP and Group CEO-VZ Business
Shares
131
Price
$13.23
Total Value
$1,737.95
Nearby Earnings
Oct 20, 2026
EPS:Est: 1.28
Revenue:Est: $34.79B
Transaction Details
| Insider | Malady Kyle |
|---|---|
| Title | EVP and Group CEO-VZ Business |
| Transaction Date | Oct 8, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Phantom Stock (unitized) |
| Derivative | Yes |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Deferred Compensation Plan |
| Filing Date | Oct 9, 2026 |
| Shares Purchased | 131 |
| Price per Share | $13.23 |
| Total Value | $1,737.95 |
| Shares Owned After | 424,644 |
| Derivative | Derivative |
| Accession Number | 0001760581-26-000067 |
| Document | View SEC Filing |